Skip to main content
TipRanks
Go Ultimate75% OFF

Moleculin Biotech (MBRX) Q4 2021 Earnings Report

2,025 Followers

MBRX Q4 2021 EPS Results

Actual EPS
-$67.50
Consensus EPS
-$73.13
Beat/Miss
Beat by +$5.63
One Year Ago EPS
-$90.00

MBRX Q4 2021 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2021
Date
03/25/2022
Time
Before Open
Conference Call
Friday, March 25, 2022
MBRX Upcoming Earnings

Moleculin Biotech's next earnings date is estimated for March 19, 2027, based on past reporting schedules.

Q4 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

MBRX Earnings History

MBRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 19, 20272026 (Q4)-8.82-52.2――
Nov 16, 20262026 (Q3)-8.87-9.59-340.497.18% (+330.81)
Aug 14, 20262026 (Q2)-31.07-28.00-24588.57% (+217.00)
May 15, 20262026 (Q1)-46.67-70.80-34579.48% (+274.20)
Mar 19, 20262025 (Q4)-122.2752.20125-58.24% (-72.80)
Nov 17, 20252025 (Q3)-6.58-17.02-71.2576.12% (+54.23)
Aug 13, 20252025 (Q2)-215.00-245.00-85071.18% (+605.00)
May 14, 20252025 (Q1)-277.50-345.00-101065.84% (+665.00)
Mar 24, 20252024 (Q4)-641.67125.00-2510104.98% (+2635.00)
Nov 11, 20242024 (Q3)-1220.00-1425.00-14250.00% (+0.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed